Short Description Decibel Therapeutics develops gene therapies for hearing loss to support healthy longevity.
Description Decibel Therapeutics is a biotechnology innovator targeting the fundamental mechanisms of aging through gene therapies for hearing loss. The company leverages advancements in regenerative medicine and collaborates with leading institutions to translate cutting‑edge science into practical interventions. By focusing on science‑backed solutions, Decibel Therapeutics aims to extend healthspan and improve quality of life across the globe.
Address 1325 Boylston St, 8th Fl, Boston, MA, USA